Geron (GERN) Equity Income (2010 - 2020)

Geron's (GERN) quarterly Equity Income came in at -$49000.0 in Q4 2020, up 58.47% quarter-over-quarter from -$118000.0 in Q3 2020.

Geron (GERN) Equity Income (2010 - 2020) Analysis & Trends

Geron has disclosed Equity Income across 5 years of filings, most recently posting -$49000.0 for Q4 2020.

  • Equity Income for Q4 2020 came in at -$49000.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2020 was $60000.0 (up 130.77% YoY), and the FY2020 annual result was $60000.0, up 130.77% from the prior year.
  • Equity Income came in at -$49000.0 for Q4 2020 at Geron, up from -$118000.0 in the prior quarter.
  • In the past five years, Equity Income ranged from a high of $422000.0 in Q2 2020 to a low of -$350000.0 in Q2 2018.
  • The 3-year median for Equity Income is -$118000.0 (2020), against an average of -$61454.5.
  • Peak annual rise in Equity Income reached 530.61% in 2020, while the deepest fall reached 298.98% in 2020.
  • Geron's Equity Income stood at -$271000.0 in 2018, then increased by 28.04% to -$195000.0 in 2019, then surged by 74.87% to -$49000.0 in 2020.
  • The last three Equity Income figures came in at -$49000.0 (Q4 2020), -$118000.0 (Q3 2020), and $422000.0 (Q2 2020), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Income (Qtr)
1 Alterity Therapeutics 788,338.31 Bn 788,338.28 Bn - -
2 Belite Bio 56,560.00 Bn 56,560.00 Bn - -
3 Quantum Biopharma 17,329.30 Bn 17,329.30 Bn - 235,807.00
4 Legend Biotech 3,341.00 Bn 3,340.71 Bn 242.10 Mn -
5 Akari Therapeutics 1,727.91 Bn 1,727.91 Bn - -
6 Evaxion A 1,536.68 Bn 1,536.67 Bn - -
7 Psyence Biomedical 238.34 Bn 238.33 Bn - -
8 Vertex Pharmaceuticals 113.42 Bn 106.17 Bn 2.59 Bn -
9 Abivax 95.45 Bn 95.45 Bn - -
10 Geron 753,046.88 753,046.88 - -

Historic Data

Download Data
DateValue
Dec 31, 2020 -49,000.00
Sep 30, 2020 -118,000.00
Jun 30, 2020 422,000.00
Mar 31, 2020 -195,000.00
Sep 30, 2019 -195,000.00
Jun 30, 2019 -98,000.00
Mar 31, 2019 98,000.00
Dec 31, 2018 -271,000.00
Sep 30, 2018 205,000.00
Jun 30, 2018 -350,000.00
Mar 31, 2018 -125,000.00
Jun 30, 2011 -168,000.00
Mar 31, 2011 -335,000.00
Dec 31, 2010 -1.21 Mn
Sep 30, 2010 -243,000.00
Jun 30, 2010 -496,000.00